To the Editor:
Before coronavirus disease (COVID-19), reports of prone positioning in nonintubated patients with acute respiratory distress syndrome suggested it may improve oxygenation and avert intubation (1–4). This potential value was magnified by the COVID-19 pandemic, prompting clinicians to implement prone positioning protocols to manage the surge of patients presenting with acute hypoxic respiratory failure (5–7). We aimed to assess the feasibility and efficacy of a patient-directed prone positioning protocol compared with usual care in nonintubated, spontaneously breathing patients hospitalized with COVID-19.
Methods
Patients
We conducted a nonblinded pragmatic randomized controlled trial in symptomatic patients hospitalized with suspected or laboratory-confirmed COVID-19. Patients were enrolled within 48 hours of admission from April 29 to August 6, 2020. Eligibility for enrollment required symptoms of COVID-19 combined with either a high clinical suspicion and a pending COVID-19 assay or a positive COVID-19 assay within 10 days. We excluded patients if they were unable to change position without assistance, pregnant, incarcerated, admitted to an intensive care unit (ICU) or transfer was imminent, mechanically ventilated, or receiving hospice.
Intervention
Patients were randomized using a 1:1 allocation to prone positioning or usual care. Those randomized to prone positioning received verbal and written instructions explaining the protocol and a tracking log, and they were offered a massage therapy cushion for comfort. Nursing documentation of patient position was collected as a secondary measure of protocol adherence. During the day, patients were instructed to position themselves in a prone (preferred), left-lateral, or right-lateral (alternati++) position every 4 hours for a duration of 1–2 hours or as long as tolerated. At night, patients were allowed to sleep in any position. Nursing staff did not instruct patients to change positions.
Endpoints
The primary endpoint was the change in partial pressure of oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio at 72 hours after admission. Secondary endpoints were change in PaO2/FiO2 at 48 hours, need for endotracheal intubation, ICU transfer, escalation in oxygen delivery system, length of stay, ventilator-free days, and in-hospital mortality. We performed nonlinear imputation of PaO2/FiO2 from oxygen saturation (SpO2)/FiO2 at the time of admission and 48 and 72 hours after admission (8).
Results
We assessed 238 patients for eligibility; 76 did not meet inclusion criteria, 51 patients declined to participate, 42 patients were already admitted to an ICU or transfer was imminent, and 39 patients were unable to provide consent. Our target enrollment was 60 patients; however, after a prespecified interim safety analysis, enrollment was stopped because of a lack of protocol adherence. A total of 30 patients were randomized, with 15 (50%) to prone positioning and 15 (50%) to usual care. Baseline characteristics were balanced between groups (Table 1).
Table 1.
Baseline Characteristics | Usual Care (n = 15) | Prone Positioning (n = 15) | Combined (N = 30) |
---|---|---|---|
Demographics | |||
Age, median (IQR), yr | 62 (49–75) | 52 (40–65) | 56.5 (45–70) |
Sex, M, n (%) | 8 (53.3) | 8 (53.3) | 16 (53.3) |
BMI, median (IQR), kg/m2 | 29.3 (24.4–32.9) | 32.9 (27.5–39.4) | 30.3 (27.4–37.4) |
Charlson Comorbidity Index, median (IQR) | 3 (1–5) | 1 (0–2) | 2 (1–4) |
Race/ethnicity, n (%) | |||
White | 6 (40.0) | 6 (40.0) | 12 (40.0) |
Latinx | 2 (13.3) | 5 (33.3) | 7 (11.2) |
African American | 2 (13.3) | 1 (6.7) | 3 (10.0) |
Pacific Islander | 3 (20.0) | 1 (6.7) | 4 (13.3) |
Asian | — | 1 (6.7) | 1 (3.3) |
American Indian or Alaskan native | 2 (13.3) | — | 2 (6.7) |
Other | — | 1 (6.7) | 1 (3.3) |
Clinical status | |||
Positive COVID-19 PCR assay, n (%) | 14 (93.3) | 15 (100) | 29 (96.7) |
Admission O2 saturation, median (IQR), % | 94 (87–96) | 94 (93–95) | 94 (90–96) |
Admission FiO2, median (IQR) | 21 (21–29) | 21 (21–29) | 21 (21–29) |
Admission oxygen delivery method, n (%) | |||
Room air | 9 (60.0) | 10 (66.7) | 19 (63.3) |
Nasal cannula | 6 (40.0) | 5 (33.3) | 11 (36.7) |
Definition of abbreviations: BMI = body mass index; COVID-19 = coronavirus disease; FiO2 = fraction of inspired oxygen; IQR = interquartile range; PCR = polymerase chain reaction.
Interim analysis revealed that protocol adherence was poor (Table 2). None of the patients completed the tracking log despite in-person or telephone reminders. Nursing documentation was available for every patient and was used in place of the tracking log. Only six (40%) patients in the prone positioning arm were observed in the prone position at least once within 72 hours of admission (Table 2). The cumulative time spent prone accounted for only 2.4% of the total time within the first 72 hours of admission (censored for discharge within 72 h), with a mean (95% confidence interval [CI]) duration of 1.6 (0.2–3.1) hours.
Table 2.
Measure | Usual Care (n = 15) | Prone Positioning (n = 15) | P Value |
---|---|---|---|
Patients observed in prone position during initial 72 h of hospitalization, n (%) | 0 (0) | 6 (40.0) | 0.017 |
Average hours observed in prone position during initial 72 h of hospitalization, mean (95% CI) | 0 (0) | 1.6 (0.2–3.1) | 0.024 |
Percentage of time observed in prone position during initial 72 h of hospitalization, % | 0 | 2.4 | — |
Definition of abbreviation: CI = confidence interval.
Eleven (36.7%) patients required supplemental oxygen upon admission, and the median (interquartile range) SpO2 was 94% (90–96%). Five (16.7%) patients were discharged within 72 hours. The remaining 25 (83.3%) patients were included in the primary analysis (Table 3). No significant difference was observed in the change in PaO2/FiO2 at 72 hours between prone positioning and usual care (mean [95% CI], −80.1 [−138.8 to −21.4] vs. −18.2 [−63.0 to 26.5]; P = 0.077). The change in PaO2/FiO2 at 48 hours was significantly worse in the prone positioning arm compared with the usual care arm (mean [95% CI], −70.5 [−116.4 to −24.6] vs. −15.0 [−45.0 to 15.0]; P = 0.036). Twelve (80%) patients in the prone positioning arm required an escalation in oxygen delivery system, five (33.3%) patients were transferred to the ICU, and two (13.3%) required endotracheal intubation/mechanical ventilation. Two deaths occurred, both in the prone positioning arm, and were deemed unrelated to study procedures. No study-related adverse events were observed.
Table 3.
Outcomes | Usual Care (n = 15) | Prone Positioning (n = 15) | P Value* |
---|---|---|---|
Primary outcome | |||
Change in PaO2/FiO2 at 72 h, mean (95% CI) | −18.2 (−63.0 to 26.5) | −80.1 (−138.8 to −21.4) | 0.077 |
Secondary outcomes | |||
Change in PaO2/FiO2 at 48 h, mean (95% CI) | −15.0 (−45.0 to 15.0) | −70.5 (−116.4 to −24.6) | 0.036 |
Length of stay, median (IQR), d | 4.6 (3.1 to 5.0) | 4.7 (2.8 to 8.2) | 0.694 |
Required escalation of O2 delivery system, n (%) | 7 (46.7) | 12 (80.0) | 0.128 |
Maximal amount of oxygen support, n (%) | 0.339 | ||
Room air | 3 (20.0) | 4 (26.7) | — |
Nasal cannula | 11 (73.3) | 7 (46.7) | — |
High-flow nasal cannula | 0 (0) | 2 (13.3) | — |
Endotracheal intubation/mechanical ventilation | 1 (6.7) | 2 (13.3) | — |
Transferred to ICU, n (%) | 2 (13.3) | 5 (33.3) | 0.390 |
Required intubation/mechanical ventilation, n (%) | 1 (6.7) | 2 (13.3) | 1.000 |
In-hospital mortality, n (%) | 0 (0) | 2 (13.3) | 0.483 |
Ventilator-free days, mean (95% CI) | 27.0 (24.8 to 29.2) | 24.3 (18.8 to 29.7) | 0.332 |
Definition of abbreviations: CI = confidence interval; FiO2 = fraction of inspired oxygen; ICU = intensive care unit; IQR = interquartile range; PaO2 = partial pressure of arterial oxygen.
P values are not adjusted for multiple comparisons.
Discussion
In this pragmatic randomized controlled trial, we investigated the feasibility and efficacy of patient-directed prone positioning among nonintubated, spontaneously breathing patients hospitalized with COVID-19. We found that adherence to our prone positioning protocol was very low, suggesting that a patient-directed approach is not feasible. Our protocol appeared safe, although it did not improve oxygenation, an unexpected finding.
Despite receiving verbal and written instructions and either telephone or in-person follow-up, none of the participants tolerated or adhered to the protocol as designed. Most patients verbalized laying prone one or two times daily for 30–90 minutes within the first 72 hours of hospitalization. Nursing documentation confirmed poor protocol adherence, with only 40% of patients assigned to the intervention being observed in the prone position. This observation reinforced our decision to stop enrollment early and conclude our protocol is not feasible. It is possible a nursing-directed protocol may improve adherence, though we opted against this approach to minimize contagion risk.
Given the considerable physiologic evidence for improved oxygenation in the prone position combined with the aforementioned poor protocol adherence, it is difficult to draw inferences from our primary and secondary outcomes. The lack of improvement in PaO2/FiO2 observed at 72 and 48 hours may represent the natural disease course of COVID-19, with little to no measurable effect of prone positioning.
Our study has several limitations, including the small sample size, which limits the power to detect outcome differences; missing data from tracking logs; lack of protocol adherence; and use of a surrogate outcome measure (i.e., imputed PaO2/FiO2). Many patients (63.3%) did not require supplemental oxygen upon admission, suggesting that they were less acutely ill compared with other studied cohorts, possibly accounting for their lack of adherence and improvement (2, 6, 9). Regardless, we believe our results are informative to future studies and urge investigators to develop respiratory therapy– (9) or nursing-directed protocols rather than relying on patient-directed protocols.
Conclusions
Our results suggest that patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19. No improvements in oxygenation were observed at 72 or 48 hours.
Footnotes
Author Contributions: S.A.J., D.J.H., M.J.F., J.Y., N.A., J.P.B., J.H.C., and M.J.L. participated in the study design, research, and manuscript preparation. S.A.J. is the guarantor of this manuscript and takes responsibility for the integrity of the work from inception to completion.
Clinical Trial Registration: ClinicalTrials.gov (NCT04368000).
Author disclosures are available with the text of this letter at www.atsjournals.org.
References
- 1. Scaravilli V, Grasselli G, Castagna L, Zanella A, Isgrò S, Lucchini A, et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study. J Crit Care. 2015;30:1390–1394. doi: 10.1016/j.jcrc.2015.07.008. [DOI] [PubMed] [Google Scholar]
- 2. Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. 2020;24:28. doi: 10.1186/s13054-020-2738-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Pérez-Nieto OR, Guerrero-Gutiérrez MA, Deloya-Tomas E, Ñamendys-Silva SA. Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit Care. 2020;24:114. doi: 10.1186/s13054-020-2821-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Valter C, Christensen AM, Tollund C, Schønemann NK. Response to the prone position in spontaneously breathing patients with hypoxemic respiratory failure. Acta Anaesthesiol Scand. 2003;47:416–418. doi: 10.1034/j.1399-6576.2003.00088.x. [DOI] [PubMed] [Google Scholar]
- 5. Ng Z, Tay WC, Ho CHB. Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients. Eur Respir J. 2020;56:2001198. doi: 10.1183/13993003.01198-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Despres C, Brunin Y, Berthier F, Pili-Floury S, Besch G. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients. Crit Care. 2020;24:256. doi: 10.1186/s13054-020-03001-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Bentley SK, Iavicoli L, Cherkas D, Lane R, Wang E, Atienza M, et al. Guidance and patient instructions for proning and repositioning of awake, nonintubated COVID-19 patients. Acad Emerg Med. 2020;27:787–791. doi: 10.1111/acem.14067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou PC, et al. NIH/NHLBI PETAL Network Collaborators. Nonlinear imputation of PaO2/FiO2 from SpO2/FiO2 among patients with acute respiratory distress syndrome. Chest. 2016;150:307–313. doi: 10.1016/j.chest.2016.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Hallifax RJ, Porter BM, Elder PJ, Evans SB, Turnbull CD, Hynes G, et al. Oxford Respiratory Group. Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience. BMJ Open Respir Res. 2020;7:e000678. doi: 10.1136/bmjresp-2020-000678. [DOI] [PMC free article] [PubMed] [Google Scholar]